Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma.
David S ShulmanPriscilla MerriamEdwin ChoyLillian M GuentherKerri L CavanaughPei-Chi KaoAndrew PosnerKetki BhushanGrace FairchildEmma BarkerKelly KlegaKimberly StegmaierBrian D CromptonWendy B LondonSteven G DuBoisPublished in: Cancer medicine (2023)
This combination lacks adequate therapeutic activity for further study, though a subset of patients had prolonged stable disease.